Stockscreener 앱 받기
2.33
1.75%
0.04
시장 영업 전:
2.32
-0.01
-0.43%
전일 마감가:
$2.29
열려 있는:
$2.3
하루 거래량:
94,791
Relative Volume:
0.25
시가총액:
$18.70M
수익:
$1.98M
순이익/손실:
$-9.63M
주가수익비율:
-1.3199
EPS:
-1.7653
순현금흐름:
$-9.76M
1주 성능:
+0.87%
1개월 성능:
+13.66%
6개월 성능:
-8.98%
1년 성능:
-31.87%
1일 변동 폭
$2.26
$2.35
1주일 범위
$2.2001
$2.39
52주 변동 폭
$1.81
$12.37
Lipocine Inc Stock (LPCN) Company Profile
명칭
Lipocine Inc
전화
801 994 7383
주소
675 ARAPEEN DRIVE, SUITE 202, SALT LAKE CITY, UT
Compare LPCN vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LPCN
Lipocine Inc
|
2.33 | 18.70M | 1.98M | -9.63M | -9.76M | -1.7653 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Lipocine Inc Stock (LPCN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-06 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2021-06-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-12-10 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2018-01-12 | 재확인 | H.C. Wainwright | Buy |
| 2018-01-11 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2017-12-08 | 재개 | H.C. Wainwright | Buy |
| 2016-10-07 | 개시 | H.C. Wainwright | Buy |
| 2015-07-22 | 개시 | ROTH Capital | Buy |
| 2015-06-23 | 개시 | Canaccord Genuity | Buy |
모두보기
Lipocine Inc 주식(LPCN)의 최신 뉴스
MSN Money - MSN
Lipocine Inc expected to post a loss of 48 cents a shareEarnings Preview - TradingView
Lipocine stock plunges after LPCN 1154 misses phase 3 primary endpoint - MSN
LPCN stock crashes 78%—here’s why - MSN
Lipocine (LPCN) price target decreased by 45.45% to 6.12 - MSN
Lipocine Announces Publication and Discussion of LPCN 1148 Manuscript at The Liver Meeting 2024 Editor's Cut Session - Quantisnow
Lipocine (LPCN) price target decreased by 15.38% to 11.22 - MSN
LPCN (Lipocine Inc.) posts narrower Q4 2025 loss than analyst estimates, shares rise modestly in trading today.Put/Call Ratio - Cổng thông tin điện tử tỉnh Tây Ninh
Lipocine (LPCN) 2026 proxy seeks director votes and 1,000,000-share incentive plan - Stock Titan
Lipocine Reshapes Board Leadership Amid Strategic Shift - TipRanks
Board reshuffle at Lipocine (NASDAQ: LPCN) as chairman exits, new independent leader named - Stock Titan
What's going on with Lipocine stock on Monday? - MSN
Lipocine (LPCN) Stock: Investment Opportunity (Trend Weakens) 2026-04-18Pro Trader Recommendations - Xã Thanh Hà
A. G. P. Maintains Lipocine(LPCN.US) With Buy Rating, Cuts Target Price to $6 - Moomoo
Quarterly Risk: What is the Moat Score of Lipocine IncMarket Growth Summary & Technical Buy Zone Confirmation - baoquankhu1.vn
Form 10-QQuarterly report [Sections 13 or 15(d)] - ADVFN
Is Lipocine (LPCN) Stock heavily shorted | Price at $2.03, Down 4.88%Catalyst Driven Stocks - Cổng thông tin điện tử Tỉnh Sơn La
Higuchi John W. buys Lipocine (LPCN) shares worth $81199 - Investing.com UK
Higuchi John W. buys Lipocine (LPCN) shares worth $81199 By Investing.com - Investing.com India
Director John Higuchi adds 40,000 Lipocine (LPCN) shares at $2.03 - Stock Titan
Lipocine (NASDAQ:LPCN) CEO Mahesh Patel Acquires 25,000 Shares of Stock - Defense World
CEO Mahesh Patel Increases Stake in Lipocine Inc with Recent Sha - GuruFocus
Higuchi John W. buys Lipocine (LPCN) shares worth $252,149 By Investing.com - Investing.com Australia
Higuchi John W. buys Lipocine (LPCN) shares worth $252,149 - Investing.com
Director John W. Higuchi buys 123K Lipocine (LPCN) shares at $2.05 - Stock Titan
Lipocine CEO Patel acquires $50,749 in LPCN stock - Investing.com UK
Lipocine CEO Patel acquires $50,749 in LPCN stock By Investing.com - Investing.com India
Lipocine (LPCN) CEO adds 25,000 shares in stock purchase - Stock Titan
Lipocine adds to PPD setbacks as Tepezza scores, batoclimab misses in TED - BioCentury
LPCN Downgraded to Neutral by HC Wainwright & Co. | LPCN Stock N - GuruFocus
Lipocine Inc (LPCN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
0.48%
자본화:
|
볼륨(24시간):